- Home
- GDHG vs CVKD Comparison
GDHG vs CVKD Comparison
Compare GDHG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- CVKD
- Stock Information
- Founded
- GDHG 2008
- CVKD 2022
- Country
- GDHG China
- CVKD United States
- Employees
- GDHG N/A
- CVKD N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- GDHG Consumer Discretionary
- CVKD Health Care
- Exchange
- GDHG Nasdaq
- CVKD Nasdaq
- Market Cap
- GDHG 20.1M
- CVKD 29.5M
- IPO Year
- GDHG 2023
- CVKD 2023
- Fundamental
- Price
- GDHG $1.27
- CVKD $12.71
- Analyst Decision
- GDHG
- CVKD Strong Buy
- Analyst Count
- GDHG 0
- CVKD 1
- Target Price
- GDHG N/A
- CVKD $32.00
- AVG Volume (30 Days)
- GDHG 1.5M
- CVKD 35.8K
- Earning Date
- GDHG 07-29-2025
- CVKD 08-06-2025
- Dividend Yield
- GDHG N/A
- CVKD N/A
- EPS Growth
- GDHG N/A
- CVKD N/A
- EPS
- GDHG N/A
- CVKD N/A
- Revenue
- GDHG $22,333,251.00
- CVKD N/A
- Revenue This Year
- GDHG N/A
- CVKD N/A
- Revenue Next Year
- GDHG N/A
- CVKD N/A
- P/E Ratio
- GDHG N/A
- CVKD N/A
- Revenue Growth
- GDHG N/A
- CVKD N/A
- 52 Week Low
- GDHG $0.51
- CVKD $5.70
- 52 Week High
- GDHG $250.00
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- GDHG 36.08
- CVKD 49.98
- Support Level
- GDHG $0.98
- CVKD $11.00
- Resistance Level
- GDHG $1.70
- CVKD $13.56
- Average True Range (ATR)
- GDHG 0.34
- CVKD 1.15
- MACD
- GDHG 0.28
- CVKD 0.25
- Stochastic Oscillator
- GDHG 62.78
- CVKD 80.97
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.